DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder
So far, genetic studies of treatment response in schizophrenia, bipolar disorder, and major depression have returned results with limited clinical utility. A gene × environment interplay has been proposed as a factor influencing not only pathophysiology but also the treatment response. The...
Main Authors: | Charanraj Goud Alladi, Bruno Etain, Frank Bellivier, Cynthia Marie-Claire |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/10/3026 |
Similar Items
-
Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
by: Jiaqi Zhou, et al.
Published: (2021-05-01) -
The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
by: Yue Zhu, et al.
Published: (2019-04-01) -
Using summary data from the Danish National Registers to estimate heritabilities for schizophrenia, bipolar disorder and major depressive disorder
by: Naomi R Wray, et al.
Published: (2012-07-01) -
Common and Specific Functional Activity Features in Schizophrenia, Major Depressive Disorder, and Bipolar Disorder
by: Yongfeng Yang, et al.
Published: (2019-02-01) -
Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia
by: Leonid O. Bryzgalov, et al.
Published: (2018-04-01)